How to Prepare Samples for Histone β-Hydroxybutyrylation Analysis?

Standard Sample Preparation Workflow for Histone β-Hydroxybutyrylation Analysis

1. Cell/Tissue Lysis and Histone Extraction

The first step in obtaining high-quality histones is to establish lysis conditions that effectively preserve post-translational modifications. Because histones are highly enriched in PTMs, lysis conditions should remain as mild as possible while simultaneously inhibiting the activity of modification-removing enzymes. For cell samples, such as conventional adherent cell lines including HEK293T and HeLa, cells are typically washed with cold PBS followed by direct lysis of nuclear components using a high-concentration acidic buffer (e.g., 0.4 M HCl). The addition of protease inhibitors and deacetylase/deacylase inhibitors (e.g., TSA and nicotinamide) to the lysis buffer is a critical step for preserving histone β-hydroxybutyrylation modifications. For tissue samples, mechanical disruption using a tissue grinder or homogenizer is generally performed prior to extraction with an acidic buffer. Throughout the procedure, samples should be maintained at low temperature (4 °C), and extraction should be performed under continuous rotation for approximately 1 hour to maximize histone recovery. Subsequently, proteins are concentrated by trichloroacetic acid (TCA) precipitation, followed by washing with pre-chilled acetone to remove residual acid and other impurities, ultimately yielding purified histone precipitates.

 

2. Histone Separation and Purification

Before analyzing specific sites such as H3K9bhb and H4K12bhb, separation and purification of histone subtypes are often required. This step not only improves analytical resolution but also facilitates targeted investigation of specific histone variants. Two commonly used approaches are employed in practice. The first is SDS-PAGE, which is suitable for small-scale samples and subsequent gel band excision analysis of specific histones. The second is reversed-phase high-performance liquid chromatography (RP-HPLC), which is more suitable for large-scale purification of specific histones, particularly H3 and H4. The appropriate method should be selected according to the experimental objective. For example, if the focus is on hydroxybutyrylation sites on histone H3, high-purity H3 fractions can be collected using HPLC prior to subsequent enzymatic digestion.

 

3. Enzymatic Digestion

Due to the unique structural characteristics of histones, enzymatic digestion frequently generates extremely short peptides, which can reduce both the sensitivity and sequence coverage in mass spectrometry analysis. Although trypsin is the most commonly used protease, its use alone is often insufficient for optimal analysis. A more effective strategy involves combinational digestion, such as the use of trypsin together with Lys-C, which generates peptides of moderate length that are more suitable for mass spectrometric detection while maintaining sufficient site coverage. Glu-C is also commonly used as an alternative enzyme, particularly when the target modification is located near glutamate residues. The digestion time is generally recommended to be controlled between 4 and 16 hours. A two-stage digestion strategy, consisting of a short pre-digestion followed by extended digestion, can produce more stable and reproducible results. In addition, buffer conditions during digestion (e.g., pH and ionic strength) should be optimized according to the specific protease used to prevent enzyme inactivation.

 

4. Enrichment of β-Hydroxybutyrylated Peptides

In unenriched peptide mixtures, β-hydroxybutyrylated peptides represent only a very small fraction and are therefore difficult to detect directly by mass spectrometry. Immunoaffinity enrichment is currently the most widely used strategy. This approach relies on high-affinity pan-Kbhb antibodies that selectively capture modified peptides via antibody-immobilized magnetic beads. During the enrichment process, the digested peptide solution is incubated with pre-activated antibody-conjugated magnetic beads under rotation at 4 °C for 8-12 hours to ensure sufficient binding. The elution step is equally critical. Solutions containing 0.1% trifluoroacetic acid (TFA) or 0.2% formic acid (FA) are typically used to gently release bound modified peptides while preserving peptide structure and modifications. Notably, the quality of the antibody directly determines the efficiency and specificity of enrichment.

 

5. Desalting Purification and LC-MS/MS Sample Preparation

Following enrichment, peptides should be desalted using C18 solid-phase extraction columns to remove buffer salts and interfering substances, thereby preventing ion suppression and reduced electrospray efficiency during mass spectrometry analysis. A typical procedure includes the following steps: the column is first activated with a high-concentration organic solvent (e.g., 50% acetonitrile) and then equilibrated with 0.1% formic acid; after sample loading, impurities are removed using a mild wash buffer; finally, the target peptides are eluted using 80% acetonitrile containing 0.1% formic acid. The eluate is then concentrated to dryness using a SpeedVac system and reconstituted in 0.1% formic acid prior to LC-MS/MS analysis. To ensure data consistency and comparability, the addition of internal standard peptides for quality control is recommended for each batch of samples, particularly when performing multi-condition comparative experiments (e.g., treatment vs. control).

Although research on histone β-hydroxybutyrylation remains an emerging field, the implementation of the above standardized sample preparation workflow can significantly improve the stability and quality of raw mass spectrometry data. In practical projects, MtoZ Biolabs has also developed standardized protocols and accumulated extensive experience in antibody screening for Kbhb modification analysis, supporting research workflows from sample preparation to data acquisition and mechanistic interpretation.